About: SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus
Creator	Dhama, Kuldeep Tiwari, Ruchi Sah, Ranjit Chaicumpa, Wanpen Singh Malik, Yashpal Sharun, Khan Chikitsa, Pashu Karam, Pal Katterine Bonilla-Aldana, D Rabaan, Ali Rodriguez-Morales, Alfonso Singh, Yashpal Upadhayay, Dayal Vishwavidyalay, Vigyan Singh, Karam Yatoo, Mohd Katterine Bonilla-Aldana, Alfonso Martinez-Pulgarin, Dayron Michalak, Izabela Patel, Shailesh Pathak, Mamta Rodriguez-Morales, Yatoo, Iqbal Chaicumpa, Dayron Deen, Pandit Go-Anusandhan, Evum Kumar Panwar, Parmod Martinez-Pulgarin, D Michalak, Wanpen Panwar, Kumar Singh, Izabela
source	Elsevier; Medline; PMC
abstract	Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome - Coronavirus-2) of the family Coronaviridae, appeared in China in December 2019. This disease was declared as posing Public Health International Emergency by World Health Organization on January 30, 2020, attained the status of a very high-risk category on February 29, and now having a pandemic status (March 11). COVID-19 has presently spread to more than 215 countries/territories while killing nearly 0.62 million humans out of cumulative confirmed infected asymptomatic or symptomatic cases accounting to almost 15 million as of July 22, 2020, within a short period of just a few months. Researchers worldwide are pacing with high efforts to counter the spread of this virus and to design effective vaccines and therapeutics/drugs. Few of the studies have shown the potential of the animal-human interface and zoonotic links in the origin of SARS-CoV-2. Exploring the possible zoonosis and revealing the factors responsible for its initial transmission from animals to humans will pave ways to design and implement effective preventive and control strategies to counter the COVID-19. The present review presents a comprehensive overview of COVID-19 and SARS-CoV-2, with emphasis on the role of animals and their jumping the cross-species barriers, experiences learned from SARS- and MERS-CoVs, zoonotic links, and spillover events, transmission to humans and rapid spread, and highlights the new advances in diagnosis, vaccine and therapies, preventive and control measures, one health concept along with recent research developments to counter this pandemic disease.
has issue date	2020-08-02(xsd:dateTime)
bibo:doi	10.1016/j.tmaid.2020.101830
bibo:pmid	32755673
has license	no-cc
sha1sum (hex)	173181c00d3de9a42674ad95e64f287ee92a5993
schema:url	https://doi.org/10.1016/j.tmaid.2020.101830
resource representing a document's title	SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus
has PubMed Central identifier	PMC7396141
has PubMed identifier	32755673
schema:publication	Travel Med Infect Dis
resource representing a document's body	covid:173181c00d3de9a42674ad95e64f287ee92a5993#body_text
is schema:about of	named entity 'SARS-CoV-2' named entity 'combat' named entity 'species barrier' named entity 'species barrier' named entity 'SARS' named entity 'zoonotic' named entity 'SARS-CoV-2' named entity 'vertical transmission' named entity 'high-risk' named entity 'faeces' named entity 'genome' named entity 'binding receptor' named entity 'viral shedding' named entity 'zoonosis' named entity 'environmental health' named entity 'RT-qPCR' named entity 'transmissibility' named entity 'DPP4' named entity 'pathogenesis' named entity 'IL4' named entity 'spillovers' named entity 'clinical signs' named entity 'prodromal' named entity 'virulence' named entity 'sexual transmission' named entity 'gastrointestinal' named entity 'zoonotic' named entity 'SARS-like coronavirus' named entity 'quarantine' named entity 'bat' named entity 'host cell' named entity 'MERS' named entity 'SARS-CoV' named entity 'public health' named entity 'Guangdong' named entity 'viral pathogens' named entity 'public health' named entity 'SARS-CoV-2' named entity 'nucleic acids' named entity 'MERS-CoV' named entity 'COVID' named entity 'MERS' named entity 'MERS' named entity 'SARS' named entity 'immune defence' named entity 'animal models' named entity 'prevention and control' named entity 'pandemics' named entity 'India' named entity 'MERS-CoV' named entity 'diarrhoea'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software